干预心脏病学家对没有手术后备的PCI的看法-国际调查结果
Christopher M Fernandez1, Adhir R Shroff2, Mladen I Vidovich2
1Section of Cardiology, University of Chicago, Chicago, Illinois, USA.
概括
干预性心脏病学家优先考虑穿皮冠状动脉干预 (PCI) 没有手术支持 (SOS) 的损伤特征. 与美国同行相比,国际运营商对高风险的PCI表示更大的信心.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗保健政策 医疗保健政策
背景情况:
- 无需手术支持 (SOS) 的皮肤冠状动脉干预 (PCI) 越来越常见.
- 专家的共识现在放宽了PCI的建议,而不需要在现场进行心脏手术.
研究的目的:
- 了解没有SOS的PCI的实践模式和操作者偏好.
- 为了确定影响PCI患者选择在没有手术备份的情况下的因素.
主要方法:
- 全球基于互联网的调查分发给干预心脏病专家.
- 调查项目涵盖了人口统计,程序偏好,人格特征和不当行为史.
主要成果:
- 517名干预心脏病专家完成了调查 (341名无SOS,176名SOS操作员).
- 在非SOS操作员中,损伤特征是PCI患者选择的关键.
- 国际运营商报告说,在没有SOS的情况下,高风险PCI的舒适度更高.
结论:
- 在没有手术备用时,损伤特征对PCI患者的选择至关重要.
- 与美国运营商相比,国际运营商对在没有手术后备的情况下进行高风险的PCI表现出更大的信心.
更多相关视频
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


